Autoimmune disorders, rheumatoid arthritis, systemic inflammation, and immune dysregulation
305 articles
JAMA publishes a timely review of IgA nephropathy, the leading cause of primary glomerulonephritis worldwide, amid a wave of new therapies.
Nephrologists from Canada and Ireland address clinical questions on IgA nephropathy, one of the most common causes of kidney failure worldwide.
Scientists are monitoring an unusual hantavirus case aboard a cruise ship, raising questions about transmission risks in confined travel settings.
A comprehensive StatPearls review covering every drug class used to treat childhood asthma, from inhalers to cutting-edge biologics.
A new oligonucleotide probe workflow recovers complete RSV and norovirus genomes from low-titer clinical samples, transforming viral surveillance.
A randomized trial shows prophylactic obinutuzumab dramatically reduces steroid-requiring cGVHD after bone marrow transplant.
Une analyse mécanistique approfondie des interventions anti-inflammaging de pointe — de la pharmacologie sénolytique et du ciblage précis des cytokines aux stratégies de reprogrammation partielle visant à restaurer l'homéostasie immunitaire juvénile.
Allez au-delà des bases de l'inflammaging pour comprendre comment le vieillissement remodèle les populations de cellules immunitaires, déclenche le SASP et maintient l'organisme dans un état d'inflammation chronique de bas grade au niveau moléculaire.
Scientists reveal how a measles antiviral also blocks Nipah virus and use structural insights to engineer more potent next-generation inhibitors.
A phase 1/2 trial finds low-dose oral NMN safely raises platelet counts in steroid-refractory ITP via a novel immunometabolic mechanism.
Early influenza infections leave a lasting immunological imprint that determines how your immune system responds to entirely different flu strains later in life.
Virtual patient replicas built from multimodal data may slash trial costs, generate synthetic control arms, and predict treatment response in IBD.
